One possible explanation for the gap is the availability of highly efficacious CAR-T therapies in the U.S. and Europe serving ...

The White House has launched a new program focused on leveraging technology and private sector partnerships to find new ways to quickly produce key pharmaceutical ingredients and finished drugs at the ...

GlobalData analysts have tipped the global market for genomic therapies to balloon to almost $90 billion by 2030, driven by ...

Taken together, the reports stand as an indictment of the entire programmatic ecosystem. Critics say the unsuitable ...

At March 31, 2025, the Company had $21.1 million in cash and cash equivalents as compared to $20.3 million in cash and cash ...

FAMAR Group, a leading European pharmaceutical CDMO, is pleased to announce the signature of an agreement to acquire a sterile production site in Homburg, Germany, from MiP Pharma. The acquisition rep ...

Assertio is a pharmaceutical company with comprehensive commercial ... Assertio's ability to successfully develop and execute its sales, marketing and promotion strategies using its sales force and ...

These GLP-1 drugs have proven effective at helping people lose weight—and are showing promise for a host of other indications ...

The U.S. and China have agreed to slash tariffs, sending markets soaring overnight, but there is also big news coming on the ...